ISRG vs. ABT, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.
Intuitive Surgical vs. Its Competitors
Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.
Intuitive Surgical has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.
Intuitive Surgical currently has a consensus price target of $588.95, suggesting a potential upside of 9.47%. Abbott Laboratories has a consensus price target of $142.61, suggesting a potential upside of 4.70%. Given Intuitive Surgical's higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.
83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Abbott Laboratories had 11 more articles in the media than Intuitive Surgical. MarketBeat recorded 65 mentions for Abbott Laboratories and 54 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.26 indicating that Intuitive Surgical is being referred to more favorably in the media.
Abbott Laboratories has a net margin of 31.89% compared to Intuitive Surgical's net margin of 28.41%. Abbott Laboratories' return on equity of 19.01% beat Intuitive Surgical's return on equity.
Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
Summary
Intuitive Surgical beats Abbott Laboratories on 9 of the 17 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Intuitive Surgical Competitors List
Related Companies and Tools
This page (NASDAQ:ISRG) was last updated on 7/1/2025 by MarketBeat.com Staff